Skip to main content
. 2024 Mar 14;19(4):875–885. doi: 10.1021/acschembio.3c00607

Figure 6.

Figure 6

Visualization and quantification of rRNA inhibition through 5-EU (5-EU: heat map; DAPI: gray). Treatment conditions were 5 nM for ActD, 10 μM for oxaliplatin and cisplatin, and 0.5 μM for phenanthriplatin and 13 in A549 cells at 24 h treatment (n = 3). Scale bar = 10 μm, ***p < 0.05, N.S. p > 0.05.